596 related articles for article (PubMed ID: 32581399)
21. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
23. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
[TBL] [Abstract][Full Text] [Related]
25. Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study.
Kan M; Yamamoto E; Niimi K; Tamakoshi K; Sekiya Y; Nishino K; Ino K; Kikkawa F
J Reprod Med; 2016 Aug; 61(7-8):373-379. PubMed ID: 30408385
[TBL] [Abstract][Full Text] [Related]
26. Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement.
Hoeijmakers YM; Eysbouts YK; Massuger LFAG; Dandis R; Inthout J; van Trommel NE; Ottevanger PB; Thomas CMG; Sweep FCGJ
Gynecol Oncol; 2021 Dec; 163(3):531-537. PubMed ID: 34602288
[TBL] [Abstract][Full Text] [Related]
27. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
28. Hydatidiform mole in Turkey: results from six centers.
Oge T; Ozalp SS; Güngör T; Yildirim Y; Sanci M; Dogan A; Ertas IE; Yetimalar H; Dilek S; Celik C
J Reprod Med; 2012; 57(5-6):259-61. PubMed ID: 22696823
[TBL] [Abstract][Full Text] [Related]
29. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
30. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
[TBL] [Abstract][Full Text] [Related]
31. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
32. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
[TBL] [Abstract][Full Text] [Related]
33. Multicenter analysis of gestational trophoblastic neoplasia in Turkey.
Ozalp SS; Telli E; Oge T; Tulunay G; Boran N; Turan T; Yenen M; Kurdoglu Z; Ozler A; Yuce K; Ulker V; Arvas M; Demirkiran F; Bese T; Tokgozoglu N; Onan A; Sanci M; Gokcu M; Tosun G; Dikmen Y; Ozsaran A; Terek MC; Akman L; Yetimalar H; Kilic DS; Gungor T; Ozgu E; Yildiz Y; Kokcu A; Kefeli M; Kuruoglu S; Yuksel H; Guvenal T; Hasdemir PS; Ozcelik B; Serin S; Dolanbay M; Arioz DT; Tuncer N; Bozkaya H; Guven S; Kulaksiz D; Varol F; Yanik A; Ogurlu G; Simsek T; Toptas T; Dogan S; Camuzoglu H; Api M; Guzin K; Caliskan E; Doger E; Cakmak B; Ilhan TT
Asian Pac J Cancer Prev; 2014; 15(8):3625-8. PubMed ID: 24870768
[TBL] [Abstract][Full Text] [Related]
34. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
Hemida RA; Toson E; Van Doorn HC
J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
[TBL] [Abstract][Full Text] [Related]
35. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
36. Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis.
Zhao P; Lu Y; Huang W; Tong B; Lu W
BMC Cancer; 2019 Jan; 19(1):13. PubMed ID: 30612545
[TBL] [Abstract][Full Text] [Related]
37. Gestational trophoblastic disease following complete hydatidiform mole in Mulago Hospital, Kampala, Uganda.
Kaye DK
Afr Health Sci; 2002 Aug; 2(2):47-51. PubMed ID: 12789101
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic study on gestational trophoblastic diseases in Japan.
Yamamoto E; Nishino K; Niimi K; Ino K
J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of hysterectomy for the treatment of invasive mole in Southern Vietnam.
Vo T; Tran T; Ho T; Le C; Pham H; Tran H; Ho N; Cao T; Vo B
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7720-7727. PubMed ID: 37667950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
